Results 1 to 5 of 5
Page 1 of 1
Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasionNg, L; Poon, RTP; Yau, WL; Chow, KM; Lam, SC; Li, HS; Yau, TCC; Law, WL; Pang, RWC201380
Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition processYau, WL; Lam, SC; Ng, L; Chow, KM; Chan, TC; Chan, JYK; Wo, YH; Ng, KTP; Man, K; Poon, RTP; Pang, RWC201383
The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistanceChow, KM; Ng, L; Lam, SC; Wong, KM; Wan, TMH; Cheng, SM; Yau, TCC; Poon, RTP; Pang, RWC201327
Enhanced therapeutic efficacy of transarterial chemoembolisation treatment in hepatocelluar carcinoma (HCC) by mTOR inhibitor RAD001: implication for a novel treatment regimen in HCCChu, ACY; Poon, RTP; Lam, SC; Chow, KM; Pang, R2011160
XIAP-associated factor 1 (XAF1), a novel target gene of p53, enhances p53-mediated apoptosis via a post-translational modification mechanism 'Manuscript in submission'Zou, B; Chim, JCS; Pang, RWC; Zeng, H; Dai, Y; Zhang, R; Lam, SC; Tan, VPY; Hung, IFN; Wang, J; Lan, HY; Wong, BCY2009187
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download